Accesso libero

Parathyroidectomy in a patient treated with emicizumab

Helen Hupston

Helen Hupston

University Hospital, Queen Elizabeth Hospital BirminghamBirmingham, UK
Profilo Orcid
Cerca questo autore su
Sciendo|Google Scholar
Hupston, Helen
  
23 dic 2019
Parathyroidectomy in a patient treated with emicizumab's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Pubblicato online: 23 dic 2019
Pagine: 51 - 53
DOI: https://doi.org/10.17225/jhp00149
Parole chiave
© 2019 Helen Hupston, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
Lingua:
Inglese
Frequenza di pubblicazione:
1 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, Scienze medicali di base, altro, Medicina clinica, Medicina clinica, altro, Farmacia, Farmacologia
Feed RSS della rivista